Skip to content
  • Members
  • Become a Member
Linkedin
  • About
    • What We Do
    • Member Directory
    • Board Members
  • Focus Areas
    • Access & Appropriate Use
    • Manufacturing
    • Research & Science
  • Resources
  • News
  • About
    • What We Do
    • Member Directory
    • Board Members
  • Focus Areas
    • Access & Appropriate Use
    • Manufacturing
    • Research & Science
  • Resources
  • News
Contact

Focus area: Access & Appropriate Use

Merck & Co., Inc – Partnering with Local Hospitals Worldwide to Implement Antimicrobial Stewardship (AMS) Programs

Leveraging global surveillance data to develop rapid diagnostics: MSD & OpGen’s Collaboration

Johnson & Johnson – Access to diagnostics and therapeutic solutions for TB and MDR-TB (with FIND Diagnostics)

Shionogi – Antimicrobial Stewardship Program

Pfizer – Massive Open Online Course on Stewardship

Pfizer – Antimicrobial Access Programs

Otsuka – FighTBack Initiative

GSK – Improving Access to Antibiotics and Vaccines

BD – Phoenix™ M50 System

BD – “Resistance Fighter” Awareness and Mobilization Campaign

← Previous
Next →

The AMR Industry Alliance brings together biotech, diagnostics, generics and research-based pharmaceutical companies, to drive and measure industry progress to curb antimicrobial resistance.

  • Follow on LinkedIn

Featured

  • 2024 Year in Review
  • Manufacturing Standard
  • Access principles
  • Member companies

Explore

  • About
  • Focus Areas
  • Resources
  • News

Get involved

  • Become a Member
  • Contact
  • Media enquiries

© 2026 AMR Industry Alliance. All rights reserved.

  • Privacy Policy
  • Terms of Use
  • Privacy Centre
  • Cookie Settings